ACADIA PHARMACEUTICALS INC
ACAD
26 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 16 9:06 PM | Kihara James | Proposed Sale | 4,000 | $17.60 | $70.4K | — | View → |
| Mar 5, 2025 | Mar 6 5:17 PM | GAROFALO ELIZABETH A. | Proposed Sale | 4,919 | $18.23 | $89.7K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | Mar 27 12:00 AM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,142 | — | 4,284(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 1,627 | — | 4,883(D) | View → |
| Mar 25, 2026 | Mar 27 12:00 AM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 6,178 | — | 12,358(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 8,138 | — | 24,414(D) | View → |
| Mar 3, 2026 | Mar 20 10:01 PM | Jonathan PooleDirector | Grant/Award | 17,275 | $22.50 | 2,010(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Grant/Award | 28,098 | $22.16 | 6,332(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Grant/Award | 117,073 | $22.16 | 26,382(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Grant/Award | 117,073 | $22.16 | 26,382(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Thomas GarnerEVP, Chief Commercial Officer | Grant/Award | 126,440 | $22.16 | 28,493(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Grant/Award | 131,122 | $22.16 | 29,548(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Adams Catherine OwenDirector, Chief Executive Officer | Grant/Award | 339,514 | $22.16 | 76,509(D) | View → |
| Feb 6, 2026 | Feb 10 11:00 PM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Option Exercise | 12,944 | — | 12,945(D) | View → |
← Previous
Page 2 of 2